SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Shields JA,Demirci H,Marr BP, et al. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005; 50: 103122.
  • 2
    Nelson BR,Hamlet KR,Gillard M, et al. Sebaceous carcinoma. J Am Acad Dermatol. 1995; 33: 115.
  • 3
    Bailet JW,Zimmerman MC,Arnstein DP,Wollman JS,Mickel RA. Sebaceous carcinoma of the head and neck. Case report and literature review. Arch Otolaryngol Head Neck Surg. 1992; 118: 12451249.
  • 4
    Chao AN,Shields CL,Krema H, et al. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology. 2001; 108: 18771883.
  • 5
    Ni C,Guo BK. Pathologic classification of meibomian gland carcinomas of eyelids: clinical and pathologic study of 156 cases. Chin Med J (Engl). 1979; 92: 671676.
  • 6
    Abdi U,Tyagi N,Maheshwari V, et al. Tumours of eyelid: a clinicopathologic study. J Indian Med Assoc. 1996; 94: 405409.
  • 7
    Ni C,Searl SS,Kuo PK, et al. Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin. 1982; 22: 2361.
  • 8
    Rao NA,Hidayet AA,McLean IW, et al. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with 5-year follow-up data. Hum Pathol. 1982; 13: 113122.
  • 9
    Wolfe JT,Yeats RP,Wick MR, et al. Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis. Am J Surg Pathol. 1984; 8: 597606.
  • 10
    Snow SN,Larson PO,Lucarelli MJ, et al. Sebaceous carcinoma of the eyelids treated by Mohs micrographic surgery: report of 9 cases with review of the literature. Dermatol Surg. 2002; 28: 623631.
  • 11
    Wick MR,Goellner JR,Wolfe JT3rd, et al. Adnexal carcinomas of the skin. II. Extraocular sebaceous carcinomas. Cancer. 1985; 56: 11631172.
  • 12
    Kivela T,Asko-Siljavaara S,Pihkala U, et al. Sebaceous carcinoma of the eyelid associated with retinoblastoma. Ophthalmology. 2001; 108: 11241128.
  • 13
    Stockl FA,Dolmetsch AM,Codere F, et al. Sebaceous carcinoma of the eyelid in an immunocompromised patient with Muir-Torre syndrome. Can J Ophthalmol. 1995; 30: 324326.
  • 14
    Sweebe EC,Cogan DG. Adenocarcinoma of the meibomian gland; a pseudochalazion entity. AMA Arch Ophthalmol. 1959; 61: 282290.
  • 15
    Weedon D. Skin Pathology. 2nd ed. London, United Kingdom: Churchill Livingstone; 2002.
  • 16
    Rao NA,McLean JW,Zimmerman LE. Sebaceous carcinoma of the eyelid and caruncle: correlation of clinico-pathologic features with prognosis. In: Jakobiec FA, ed. Ocular and Adnexal Tumors. Birmingham, United Kingdom: Aesculapuis; 1978: 461476.
  • 17
    Jensen ML. Extraocular sebaceous carcinoma of the skin with visceral metastases: case report. J Cutan Pathol. 1990; 17: 117121.
  • 18
    Prioleau PG,Santa Cruz DJ. Sebaceous gland neoplasia. J Cutan Pathol. 1984; 11: 396414.
  • 19
    Thomas CJ,Wood GC,Marks VJ. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience. Dermatol Surg. 2007; 33: 333339.
  • 20
    Pardo FS,Wang CC,Albert D, et al. Sebaceous carcinoma of the ocular adnexa: radiotherapeutic management. Int J Radiat Oncol Biol Phys. 1989; 17: 643647.
  • 21
    Matsumoto CS,Nakatsuka K,Matsuo K, et al. Sebaceous carcinoma responds to radiation therapy. Ophthalmologica. 1995; 209: 280283.
  • 22
    Yen MT,Tse DT,Wu X, et al. Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of 2 cases and review of the literature. Ophthal Plast Reconstr Surg. 2000; 16: 211215.
  • 23
    Shields CL,Naseripour M,Shields JA, et al. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma. Ophthalmology. 2002; 109: 21292133.
  • 24
    Murthy R,Honavar SG,Burman S, et al. Neoadjuvant chemotherapy in the management of sebaceous gland carcinoma of the eyelid with regional lymph node metastasis. Ophthal Plast Reconstr Surg. 2005; 21: 307309.
  • 25
    Duman DG,Ceyhan BB,Celikel T, et al. Extraorbital sebaceous carcinoma with rapidly developing visceral metastases. Dermatol Surg. 2003; 29: 987989.
  • 26
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER Limited-Use Data (1973-2004). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2007, based on the November 2006 submission. Available at: www.seer.cancer.gov Accessed May 25, 2007.
  • 27
    National Cancer Institute. Characteristics of the SEER population compared with the total United States population. Available at:http://seer.cancer.gov/registries/characteristics.html Accessed May 27, 2008.
  • 28
    Fritz A,Percy C,Jack A,Sobin LH,Parkin MD, eds. International Classification of Diseases for Oncology.3rd ed. Geneva, Switzerland: World Health Organization; 2000.
  • 29
    Anderson RN,Rosenberg HM. Age standardization of death rates: implementation of the Year 2000 standard. Natl Vital Stat Rep. 1998; 47: 116, 20.
  • 30
    Fay MP. Approximate confidence intervals for rate ratios from directly standardized rates with sparse data. Commun Stat Theory Methods. 1999; 28: 21412160.
  • 31
    National Cancer Institute. Number of persons by race and Hispanic ethnicity for SEER participants (2000 Census data). Available at:http://seer.cancer.gov/registries/data.html [Accessed May 27, 2008].
  • 32
    Doxanas MT,Green WR. Sebaceous gland carcinoma. Arch Opthalmol. 1984; 102: 245249.